Austria Dialysis Market Analysis Report 2022 to 2030
insights10marketing
42 views
63 slides
Jul 30, 2024
Slide 1 of 63
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
About This Presentation
This report presents a strategic analysis of the Austria Dialysis Market Analysis and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook...
Slide Content
Austria Dialysis Market Analysis
A sample report on
A sample report on
This report presents a strategic analysis of the Austria Dialysis
Market Analysis and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, main players, growth and demand drivers,
challenges & future outlook, etc. This is one of the most comprehensive
reports about the Austria Dialysis Market Analysis, and offers
unmatched value, accuracy, and expert insights.
Market Analysis and a forecast for its development in the medium and
long term. It provides a comprehensive overview of the market value,
dynamics, segmentation, main players, growth and demand drivers,
challenges & future outlook, etc. This is one of the most comprehensive
reports about the Austria Dialysis Market Analysis, and offers
unmatched value, accuracy, and expert insights.
3 A Sample Report on Austria Dialysis Market Analysis I Confidential
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Report Scope
Report Attribute Details
Number of Pages 70-80
Base Year for Estimation 2023
Forecast Period 2024-2030
Report Coverage
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends,
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape,
Reimbursement Scenario
Quantitative Units Revenue in USD Million/Billion (Mn/Bn)
Research Approach Secondary Research (60%), Primary Research (40%)
Report Scope
4 A Sample Report on Austria Dialysis Market Analysis I Confidential
CONTENT PG. NO.
1. Market Overview 07-15
1.1. Dialysis Overview
1.2. Statistics at a Glance: Dialysis in the World
1.3. Healthcare Scenario in the World
1.4. Austria Overview
1.5. Economic Overview: Austria
1.6. Statistics at a Glance: Dialysis in the Austria
1.7. Healthcare Scenario in Austria
1.8. Budget of Austria Government for Public Insurance
2. Overview of Types of Dialysis 16-17
2.1 Types of Dialysis Overview
3. Market Size and Forecasting 18-23
3.1. Market size and forecasts (Excel and Methodology)
Table of Content
CONTENT PG. NO.
1. Market Overview 07-15
1.1. Dialysis Overview
1.2. Statistics at a Glance: Dialysis in the World
1.3. Healthcare Scenario in the World
1.4. Austria Overview
1.5. Economic Overview: Austria
1.6. Statistics at a Glance: Dialysis in the Austria
1.7. Healthcare Scenario in Austria
1.8. Budget of Austria Government for Public Insurance
2. Overview of Types of Dialysis 16-17
2.1 Types of Dialysis Overview
3. Market Size and Forecasting 18-23
3.1. Market size and forecasts (Excel and Methodology)
Table of Content
5 A Sample Report on Austria Dialysis Market Analysis I Confidential
CONTENT PG. NO.
3.2. Snapshot of Dialysis Market Segmentation
3.2.1. By Product and Services
3.2.2. By Types
3.2.3. By End Users
4. Market Dynamics 24-29
4.1. Market Growth Drivers
4.2. Market Restraints
5. Competitive Landscape 30-37
5.1. Major Market Share
5.2 Key Players in Austria Dialysis Market Analysis
5.2.1. Novartis AG Austria
5.2.2. Company-2
Table of Content
CONTENT PG. NO.
3.2. Snapshot of Dialysis Market Segmentation
3.2.1. By Product and Services
3.2.2. By Types
3.2.3. By End Users
4. Market Dynamics 24-29
4.1. Market Growth Drivers
4.2. Market Restraints
5. Competitive Landscape 30-37
5.1. Major Market Share
5.2 Key Players in Austria Dialysis Market Analysis
5.2.1. Novartis AG Austria
5.2.2. Company-2
Table of Content
6 A Sample Report on Austria Dialysis Market Analysis I Confidential
CONTENT PG. NO.
5.2.3. Company-3
5.2.4. Company-4
5.2.5. Company-5
5.2.6. Company-6
5.2.7. Company-7
5.2.8. Company-8
5.2.9. Company-9
5.2.10. Company-10
6. Reimbursement Scenario 38-42
6.1. Reimbursement Regulation in Austria
6.2. Reimbursement Process
Table of Content
CONTENT PG. NO.
5.2.3. Company-3
5.2.4. Company-4
5.2.5. Company-5
5.2.6. Company-6
5.2.7. Company-7
5.2.8. Company-8
5.2.9. Company-9
5.2.10. Company-10
6. Reimbursement Scenario 38-42
6.1. Reimbursement Regulation in Austria
6.2. Reimbursement Process
Table of Content
Austria Dialysis Market Analysis
1. Market Overview
1. Market Overview
▪Dialysis isa procedure to remove waste products and excess fluid from the blood when the kidneys
stop working properly. It often involves diverting blood to a machine to be cleaned.
▪There are two main types of dialysis :
oHaemodialysis :With hemodialysis, a machine removes blood from your body, filters it through
a dialyzer (artificial kidney) and returns the cleaned blood to your body.
oPeritoneal Dialysis : With peritoneal dialysis, tiny blood vessels inside the abdominal lining
(peritoneum) filter blood through the aid of a dialysis solution. It can be automated or
continuous.
Benefits of Dialysis
▪Better Control: Dialysis removes waste and extra fluids from the body. This prevents them from building up.
▪Maintaining Levels: Blood pressure level can be maintained. Keeps safe level of minerals like potassium,
sodium, calcium, and bicarbonate.
Risks of Dialysis:
▪Infection: Some people have problems with the AV fistula or graft. There are chances to develop an infection,
poor blood flow or a blockage from scar tissue or a blood clot.
▪Weak Muscle or Weight Gain: Using the abdominal catheter and pumping belly full of fluid can weaken
abdominal muscles over time. Patient may develop a hernia. During peritoneal dialysis, body absorbs dextrose,
a sugar, from the dialysis solution. Over time, this extra sugar can lead to weight gain.
1.1 Dialysis Overview
stop working properly. It often involves diverting blood to a machine to be cleaned.
▪There are two main types of dialysis :
oHaemodialysis :With hemodialysis, a machine removes blood from your body, filters it through
a dialyzer (artificial kidney) and returns the cleaned blood to your body.
oPeritoneal Dialysis : With peritoneal dialysis, tiny blood vessels inside the abdominal lining
(peritoneum) filter blood through the aid of a dialysis solution. It can be automated or
continuous.
Benefits of Dialysis
▪Better Control: Dialysis removes waste and extra fluids from the body. This prevents them from building up.
▪Maintaining Levels: Blood pressure level can be maintained. Keeps safe level of minerals like potassium,
sodium, calcium, and bicarbonate.
Risks of Dialysis:
▪Infection: Some people have problems with the AV fistula or graft. There are chances to develop an infection,
poor blood flow or a blockage from scar tissue or a blood clot.
▪Weak Muscle or Weight Gain: Using the abdominal catheter and pumping belly full of fluid can weaken
abdominal muscles over time. Patient may develop a hernia. During peritoneal dialysis, body absorbs dextrose,
a sugar, from the dialysis solution. Over time, this extra sugar can lead to weight gain.
1.1 Dialysis Overview
9 A Sample Report on Austria Dialysis Market Analysis I Confidential
1.2 Statistics at a Glance: Dialysis in The World
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2 Mn+
People are on Dialysis
worldwide to stay alive
191.5
Per 1000 person years
was the mortality due to
dialysis in 2021
6.5%
Is the average growth rate
of Dialysis global market
from 2023 to 2030.
Taiwan
Tops in the use of Dialysis
Illustrative
1.2 Statistics at a Glance: Dialysis in The World
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
2 Mn+
People are on Dialysis
worldwide to stay alive
191.5
Per 1000 person years
was the mortality due to
dialysis in 2021
6.5%
Is the average growth rate
of Dialysis global market
from 2023 to 2030.
Taiwan
Tops in the use of Dialysis
Illustrative
10 A Sample Report on Austria Dialysis Market Analysis I Confidential
Austria Market
~$xx Bn Market
➢Africa: $_ _
➢APAC: $_ _
➢Europe: $_ _
➢LATAM: $_ _
➢Middle East: $_ _
➢North America: $_ _
Regional Analysis
Illustrative
1.3 Healthcare Scenario in the World
Austria Market
~$xx Bn Market
➢Africa: $_ _
➢APAC: $_ _
➢Europe: $_ _
➢LATAM: $_ _
➢Middle East: $_ _
➢North America: $_ _
Regional Analysis
Illustrative
1.3 Healthcare Scenario in the World
11 A Sample Report on Austria Dialysis Market Analysis I Confidential
Illustrative
8.97 Mn
Is the population of
Austria, in June 2024
$57081
Is the Gross Domestic
Product (GDP) in Austria
in 2023
43.1 years
Is the median age in Austria,
in 2023
$7275.4
Is the per capita national
health expenditure in
2022
1.4 Austria Overview
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will get an
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Illustrative
8.97 Mn
Is the population of
Austria, in June 2024
$57081
Is the Gross Domestic
Product (GDP) in Austria
in 2023
43.1 years
Is the median age in Austria,
in 2023
$7275.4
Is the per capita national
health expenditure in
2022
1.4 Austria Overview
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will get an
understanding of the demographics of the
country/region, which includes the
population, GDP, healthcare expenditure
and other details related to the topic
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
12 A Sample Report on Austria Dialysis Market Analysis I Confidential
2016 2017 2018 2019 2020 2021 2022 2023
Population of Austria in Mn, (2016-2023) GDP of Austria, (2022-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
MaleFemale
By Age GroupBy Gender
▪In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
1.5 Economic Overview: Austria
2015 2016 2017 2018 2019 2020 2021 2022
2016 2017 2018 2019 2020 2021 2022 2023
Population of Austria in Mn, (2016-2023) GDP of Austria, (2022-2030)
Population Split (2023)
55-64
0-14
15-24
25-54
65+
MaleFemale
By Age GroupBy Gender
▪In this section you will get an understanding of the demographics
of the country/region, which includes the population, GDP,
healthcare expenditure and other details related to the topic
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Illustrative
1.5 Economic Overview: Austria
2015 2016 2017 2018 2019 2020 2021 2022
13 A Sample Report on Austria Dialysis Market Analysis I Confidential
Illustrative
128.8
Per Mn is the prevalence
of Dialysis in 2021
12.3%
Is the CKD
prevalence(stage G3-G5)
among women in 2021
6.1%
Is the CKD
prevalence(stage G3-
G5) among men in 2021
31297
Patients with ESRD
entered Dialysis from
1965 to 2018
1.6 Statistics at a Glance: Dialysis in Austria
▪In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic for Austria
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Illustrative
128.8
Per Mn is the prevalence
of Dialysis in 2021
12.3%
Is the CKD
prevalence(stage G3-G5)
among women in 2021
6.1%
Is the CKD
prevalence(stage G3-
G5) among men in 2021
31297
Patients with ESRD
entered Dialysis from
1965 to 2018
1.6 Statistics at a Glance: Dialysis in Austria
▪In this section you will get an
understanding of the topic, which includes
the prevalence of the disease, the
application of medical devices, new
technology, and other details related to the
topic for Austria
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
14 A Sample Report on Austria Dialysis Market Analysis I Confidential
Public Healthcare
▪Health insurance is mandatory in Austria, with 99.9% of the
population covered through Social Health Insurance (SHI) funds in
2019
▪Patients have free choice of doctors and can visit specialists
without a referral, although some insurance plans may require
one.
Private Healthcare
▪About one-third of Austrians have supplementary private health
insurance
▪This covers additional services such as quicker access to
specialists, private rooms in hospitals, and advanced treatment
options, including certain dialysis services
Insurance
▪Austria's statutory health insurance system covers the essential
costs of dialysis treatments for all residents
▪This includes hemodialysis, peritoneal dialysis, and home dialysis
▪SHI is funded through mandatory contributions from employees
and employers, with additional support from the government for
certain groups such as retirees and low-income individuals
Government Programs
▪Austria has implemented DMPs(Disease Management Programs)
to provide structured care for patients with chronic kidney disease
▪These programs focus on early detection, regular monitoring, and
comprehensive management of CKD to prevent progression to
end-stage renal disease (ESRD)
1.7 Healthcare Scenario in Austria
Illustrative
Public Healthcare
▪Health insurance is mandatory in Austria, with 99.9% of the
population covered through Social Health Insurance (SHI) funds in
2019
▪Patients have free choice of doctors and can visit specialists
without a referral, although some insurance plans may require
one.
Private Healthcare
▪About one-third of Austrians have supplementary private health
insurance
▪This covers additional services such as quicker access to
specialists, private rooms in hospitals, and advanced treatment
options, including certain dialysis services
Insurance
▪Austria's statutory health insurance system covers the essential
costs of dialysis treatments for all residents
▪This includes hemodialysis, peritoneal dialysis, and home dialysis
▪SHI is funded through mandatory contributions from employees
and employers, with additional support from the government for
certain groups such as retirees and low-income individuals
Government Programs
▪Austria has implemented DMPs(Disease Management Programs)
to provide structured care for patients with chronic kidney disease
▪These programs focus on early detection, regular monitoring, and
comprehensive management of CKD to prevent progression to
end-stage renal disease (ESRD)
1.7 Healthcare Scenario in Austria
Illustrative
15 A Sample Report on Austria Dialysis Market Analysis I Confidential
1.8 Budget of Austria Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20312022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
1.8 Budget of Austria Government for Public Insurance
Proposed Budget By Category
Outlays 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20312022-31
In Billions Of Dollars
Medicare
$769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633
As % Of GDP 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7%
▪National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE
▪Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE
▪Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE
▪Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE
▪Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020
▪Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020
▪Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020
▪Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health
spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
Austria Dialysis Market Analysis
2. Overview of Types of Dialysis
2. Overview of Types of Dialysis
17 A Sample Report on Austria Dialysis Market Analysis I Confidential
2.1 Types of Dialysis
▪Location: Performed at a dialysis center or in the comfort of your home
▪Frequency: Typically 3-5 times a week for several hours each session
▪Procedure: Vascular Access: A necessary first step to create an access point
for blood flow
▪Involves:
oTemporary Catheter: Initially placed in a large vein, usually in the neck, for
short-term dialysis needs
oFistula: A permanent connection created surgically between an artery and
vein in your arm, preferred for long-term dialysis.
▪Dialysis Machine:
oBlood is withdrawn through the access point & then passes through a
dialyzer, a special filter that acts like an artificial kidney, removing waste
products and excess fluid
oCleaned blood is then returned to your body
▪Activity During Treatment: Due to being connected to the machine, patients
remain seated or lying down for the entire dialysis session, limiting other
activities
▪Ability to Work: While dialysis sessions require dedicated time, most patients
can resume work or other activities on non-dialysis days
▪Side Effects: Fatigue and low blood pressure are common side effects
▪Diet: Dietary restrictions are crucial. These may include limiting salt, water
intake, and certain foods high in potassium and phosphorus
▪Location: Performed conveniently at home, allowing for greater flexibility
▪Frequency: Daily exchanges, typically 4-6 times a day or night
▪Duration: Each exchange takes about 30-45 minutes, with a total daily
treatment time of 3-5 hours
▪Procedure:
oCatheter Insertion: A minimally invasive laparoscopic surgery places a
catheter in the abdominal cavity. This access point allows for fluid
exchange
▪Daily Exchanges:
oDialysis solution (dialysate) fills the abdomen through the catheter, it
absorbs waste and fluid from your blood through the peritoneum lining
oUsed dialysate is then drained out and discarded
▪Activity During Treatment: Exchanges can be done at night, minimizing
disruption to daily activities. This treatment offers greater flexibility for work,
travel, and hobbies
▪Ability to Work: With nighttime exchanges, most patients can maintain
normal work schedules and daily routines
▪Side Effects: The main concerns are infection of the catheter or abdomen
and potential limitations in the membrane's filtering ability
▪Diet: Peritoneal dialysis generally allows for fewer dietary restrictions
compared to hemodialysis
Illustrative
Hemodialysis Peritoneal Dialysis
2.1 Types of Dialysis
▪Location: Performed at a dialysis center or in the comfort of your home
▪Frequency: Typically 3-5 times a week for several hours each session
▪Procedure: Vascular Access: A necessary first step to create an access point
for blood flow
▪Involves:
oTemporary Catheter: Initially placed in a large vein, usually in the neck, for
short-term dialysis needs
oFistula: A permanent connection created surgically between an artery and
vein in your arm, preferred for long-term dialysis.
▪Dialysis Machine:
oBlood is withdrawn through the access point & then passes through a
dialyzer, a special filter that acts like an artificial kidney, removing waste
products and excess fluid
oCleaned blood is then returned to your body
▪Activity During Treatment: Due to being connected to the machine, patients
remain seated or lying down for the entire dialysis session, limiting other
activities
▪Ability to Work: While dialysis sessions require dedicated time, most patients
can resume work or other activities on non-dialysis days
▪Side Effects: Fatigue and low blood pressure are common side effects
▪Diet: Dietary restrictions are crucial. These may include limiting salt, water
intake, and certain foods high in potassium and phosphorus
▪Location: Performed conveniently at home, allowing for greater flexibility
▪Frequency: Daily exchanges, typically 4-6 times a day or night
▪Duration: Each exchange takes about 30-45 minutes, with a total daily
treatment time of 3-5 hours
▪Procedure:
oCatheter Insertion: A minimally invasive laparoscopic surgery places a
catheter in the abdominal cavity. This access point allows for fluid
exchange
▪Daily Exchanges:
oDialysis solution (dialysate) fills the abdomen through the catheter, it
absorbs waste and fluid from your blood through the peritoneum lining
oUsed dialysate is then drained out and discarded
▪Activity During Treatment: Exchanges can be done at night, minimizing
disruption to daily activities. This treatment offers greater flexibility for work,
travel, and hobbies
▪Ability to Work: With nighttime exchanges, most patients can maintain
normal work schedules and daily routines
▪Side Effects: The main concerns are infection of the catheter or abdomen
and potential limitations in the membrane's filtering ability
▪Diet: Peritoneal dialysis generally allows for fewer dietary restrictions
compared to hemodialysis
Illustrative
Hemodialysis Peritoneal Dialysis
Austria Dialysis Market Analysis
3. Market Size and Forecasting
3. Market Size and Forecasting
19 A Sample Report on Austria Dialysis Market Analysis I Confidential
▪In this section you will get an
understanding of the overall Dialysis
Market in Austria, which includes the
market size, current trends and other
details related to the topic
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
XX
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Austria Dialysis Market Analysis Forecast, 2023-2030
Click on the icon to know the calculations and assumption
20232024202520262027202820292030
Major Markets Patient
($Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Austria Patient Size ($Bn)0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75%21.70%23.56%23.45%23.42%23.39%23.34%23.45%
Global Market Size ($Bn)3,6203,7803,9504,1284,3144,5084,7114,937
Austria Market Size ($Bn)61 74 84 87 91 95 99 106
Illustrative
3.1 Market size and forecasts (Excel and Methodology)
▪In this section you will get an
understanding of the overall Dialysis
Market in Austria, which includes the
market size, current trends and other
details related to the topic
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
XX
2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F
Austria Dialysis Market Analysis Forecast, 2023-2030
Click on the icon to know the calculations and assumption
20232024202520262027202820292030
Major Markets Patient
($Mn)
2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12
Austria Patient Size ($Bn)0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73
% of Patients 18.75%21.70%23.56%23.45%23.42%23.39%23.34%23.45%
Global Market Size ($Bn)3,6203,7803,9504,1284,3144,5084,7114,937
Austria Market Size ($Bn)61 74 84 87 91 95 99 106
Illustrative
3.1 Market size and forecasts (Excel and Methodology)
20 A Sample Report on Austria Dialysis Market Analysis I Confidential
▪In this section you will get an understanding of the segmentations which will cover the Austria Dialysis Market Analysis
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Product
Dialysis Machine &
Equipment
Dialysis Consumables
Dialysis Drugs
Type
Hemodialysis
Peritoneal Dialysis
End User
Dialysis Centers & Hospitals
Home Care
Illustrative
3.2 Snapshot of Austria Dialysis Market Segmentation
▪In this section you will get an understanding of the segmentations which will cover the Austria Dialysis Market Analysis
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Product
Dialysis Machine &
Equipment
Dialysis Consumables
Dialysis Drugs
Type
Hemodialysis
Peritoneal Dialysis
End User
Dialysis Centers & Hospitals
Home Care
Illustrative
3.2 Snapshot of Austria Dialysis Market Segmentation
21 A Sample Report on Austria Dialysis Market Analysis I Confidential
Equipment
Consumables
Dialysis Drugs
Illustrative
3.2.1 Market Segmentation: By Products and Services
▪Individual Customers is a significant
component of the overall Dialysis Market in
Austria
▪It has the maximum market share in Austria
Dialysis Market with approximately xx%
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Austria Dialysis Market Analysis Share by Products and
Services (2022)
Equipment
Consumables
Dialysis Drugs
Illustrative
3.2.1 Market Segmentation: By Products and Services
▪Individual Customers is a significant
component of the overall Dialysis Market in
Austria
▪It has the maximum market share in Austria
Dialysis Market with approximately xx%
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Austria Dialysis Market Analysis Share by Products and
Services (2022)
22 A Sample Report on Austria Dialysis Market Analysis I Confidential
Haemodialysis
Peritoneal
Dialysis
Illustrative
3.2.2 Market Segmentation: By Type
▪Retail Stores has the maximum market
share in Austria Dialysis Market with
approximately xx%
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Austria Dialysis Market Analysis Share, By
Type (2022)
Haemodialysis
Peritoneal
Dialysis
Illustrative
3.2.2 Market Segmentation: By Type
▪Retail Stores has the maximum market
share in Austria Dialysis Market with
approximately xx%
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Austria Dialysis Market Analysis Share, By
Type (2022)
23 A Sample Report on Austria Dialysis Market Analysis I Confidential
In-Centre
Dialysis
Home Dialysis
Illustrative
3.2.3 Market Segmentation: By Type
▪Preventive Care has the maximum market
share in Austria Dialysis Market with
approximately xx%
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Austria Dialysis Market Analysis Share, By
End User (2022)
In-Centre
Dialysis
Home Dialysis
Illustrative
3.2.3 Market Segmentation: By Type
▪Preventive Care has the maximum market
share in Austria Dialysis Market with
approximately xx%
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Austria Dialysis Market Analysis Share, By
End User (2022)
Austria Dialysis Market Analysis
4. Market Dynamics
4. Market Dynamics
25 A Sample Report on Austria Dialysis Market Analysis I Confidential
4. Snapshot Of Market Growth Drivers And Restraints
4.1.1
Rise in the
prevalence of Chronic
Kidney Disease
(CKD) in Austria
4.1.2
Increasing aging
population
4.1.3
Improved
technological
advancements
4.2.1
Limited Healthcare
Workforce
4.2.2
Regulatory and
Compliance
Challenges
Illustrative
4. Snapshot Of Market Growth Drivers And Restraints
4.1.1
Rise in the
prevalence of Chronic
Kidney Disease
(CKD) in Austria
4.1.2
Increasing aging
population
4.1.3
Improved
technological
advancements
4.2.1
Limited Healthcare
Workforce
4.2.2
Regulatory and
Compliance
Challenges
Illustrative
26 A Sample Report on Austria Dialysis Market Analysis I Confidential
4.1.1 Rise in the Prevalence of Chronic Kidney Disease in Austria
Illustrative
▪Approximately 10% of the global population is affected by CKD,
and Austria follows a similar trend. The number of patients with
end-stage renal disease (ESRD) requiring dialysis is growing. In
2020, Austria had about 5,000 dialysis patients, with this number
expected to rise as the prevalence of CKD increases
▪This rise in disease incidence acts as a potent market driver for
the development and distribution of innovative treatments,
emphasizing the critical role of pharmaceutical companies and
healthcare providers in addressing this escalating health issue
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include
data, analysis, trends, and other relevant information related to
the topic or subject matter of interest
2010 2022 2030
Rise of Chronic Kidney Disease
4.1.1 Rise in the Prevalence of Chronic Kidney Disease in Austria
Illustrative
▪Approximately 10% of the global population is affected by CKD,
and Austria follows a similar trend. The number of patients with
end-stage renal disease (ESRD) requiring dialysis is growing. In
2020, Austria had about 5,000 dialysis patients, with this number
expected to rise as the prevalence of CKD increases
▪This rise in disease incidence acts as a potent market driver for
the development and distribution of innovative treatments,
emphasizing the critical role of pharmaceutical companies and
healthcare providers in addressing this escalating health issue
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include
data, analysis, trends, and other relevant information related to
the topic or subject matter of interest
2010 2022 2030
Rise of Chronic Kidney Disease
27 A Sample Report on Austria Dialysis Market Analysis I Confidential
▪In 2023, around 19% of the population was aged 65 and over,
and this number is projected to increase significantly in the
coming years. Older adults are more likely to develop CKD,
increasing the demand for dialysis services
▪Average life expectancy in Austria is around 81 years, with
continuous improvements in healthcare contributing to longer
lifespans and a higher prevalence of age-related diseases
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include
data, analysis, trends, and other relevant information related to
the topic or subject matter of interest
Illustrative
4.1.2 Increasing Aging Population
2010 2022 2030
Growth of Geriatric Population
▪In 2023, around 19% of the population was aged 65 and over,
and this number is projected to increase significantly in the
coming years. Older adults are more likely to develop CKD,
increasing the demand for dialysis services
▪Average life expectancy in Austria is around 81 years, with
continuous improvements in healthcare contributing to longer
lifespans and a higher prevalence of age-related diseases
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include
data, analysis, trends, and other relevant information related to
the topic or subject matter of interest
Illustrative
4.1.2 Increasing Aging Population
2010 2022 2030
Growth of Geriatric Population
28 A Sample Report on Austria Dialysis Market Analysis I Confidential
4.1.3 Improved Technological Advancements
▪Advances in dialysis machine technology, including improved efficiency, patient monitoring systems, and user-friendly interfaces, enhance
treatment outcomes and patient experience
▪Innovations in home dialysis equipment and telemedicine support are making it easier for patients to receive treatment at home, reducing the
burden on healthcare facilities and improving patient quality of life
▪The adoption of home dialysis is expected to grow by 5-7% annually
▪Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
4.1.3 Improved Technological Advancements
▪Advances in dialysis machine technology, including improved efficiency, patient monitoring systems, and user-friendly interfaces, enhance
treatment outcomes and patient experience
▪Innovations in home dialysis equipment and telemedicine support are making it easier for patients to receive treatment at home, reducing the
burden on healthcare facilities and improving patient quality of life
▪The adoption of home dialysis is expected to grow by 5-7% annually
▪Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be
presented in the final report
▪In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or
subject matter of interest
Illustrative
29 A Sample Report on Austria Dialysis Market Analysis I Confidential
4.2.1 Limited Healthcare Workforce
▪Austria has about 5.1 physicians and 8.6 nurses per 1,000
inhabitants
▪However, the demand for specialized nephrologists and dialysis
nurses is growing faster than the supply, leading to workforce
shortages that can impact the quality and accessibility of care
▪Additionally, retaining skilled healthcare workers in the face of
increasing workloads and burnout is a challenge
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
4.2.2 Regulatory and Compliance Challenges
▪Approval process for new dialysis equipment and technologies is
stringent, managed by the Austrian Medicines and Medical
Devices Agency (AGES)
▪This can delay the introduction of innovative treatments and
equipment into the market
▪Regular inspections and compliance with rigorous standards are
essential but can be resource-intensive for dialysis providers
▪Ensuring ongoing adherence to these standards requires
significant investment in quality assurance programs
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth.
Illustrative
4.2 Market Restraints
4.2.1 Limited Healthcare Workforce
▪Austria has about 5.1 physicians and 8.6 nurses per 1,000
inhabitants
▪However, the demand for specialized nephrologists and dialysis
nurses is growing faster than the supply, leading to workforce
shortages that can impact the quality and accessibility of care
▪Additionally, retaining skilled healthcare workers in the face of
increasing workloads and burnout is a challenge
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
4.2.2 Regulatory and Compliance Challenges
▪Approval process for new dialysis equipment and technologies is
stringent, managed by the Austrian Medicines and Medical
Devices Agency (AGES)
▪This can delay the introduction of innovative treatments and
equipment into the market
▪Regular inspections and compliance with rigorous standards are
essential but can be resource-intensive for dialysis providers
▪Ensuring ongoing adherence to these standards requires
significant investment in quality assurance programs
▪Please be aware that this sample report is intended to provide
you with a brief overview of the kind of information and analysis
that will be presented in the final report
▪In order to obtain access to all of the information that you are
seeking, you will need to purchase the final report
▪Final report will be comprehensive and detailed, and it will
include data, analysis, trends, and other relevant information
related to the topic or subject matter of interest
Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth.
Illustrative
4.2 Market Restraints
Austria Dialysis Market Analysis
5. Competitive Landscape
5. Competitive Landscape
31 A Sample Report on Austria Dialysis Market Analysis I Confidential
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
Revenue of Major players in the Austria Dialysis Market
Analysis ($ Mn)
Illustrative
5.1 Major Market Share
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Company 1
Company 2
Company 3
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
Revenue of Major players in the Austria Dialysis Market
Analysis ($ Mn)
Illustrative
5.1 Major Market Share
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
32 A Sample Report on Austria Dialysis Market Analysis I Confidential
Medtronic1 B. Braun Medical6
Baxter2 SB-KAWASUMI7
Fresenius Kabi3 Diaverum8
Becton Dickinson4 Nipro9
Merck5 Toray Industries10
5.2 Key Players in Austria Dialysis Market Analysis
Illustrative
▪Here is the list of top 10 companies based
on company revenues which will cover in
the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oDistribution and Vendor Partners
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
Medtronic1 B. Braun Medical6
Baxter2 SB-KAWASUMI7
Fresenius Kabi3 Diaverum8
Becton Dickinson4 Nipro9
Merck5 Toray Industries10
5.2 Key Players in Austria Dialysis Market Analysis
Illustrative
▪Here is the list of top 10 companies based
on company revenues which will cover in
the final report
▪Each company will have slides for
oOverview
oKey details
oOfferings
oName of products
oRecent activities/ Press Coverage
oDistribution and Vendor Partners
oMergers, Acquisitions and
Collaboration
oFinancials
▪If there are specific companies that you
would like to be included in the report,
please let us know via email
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
33 A Sample Report on Austria Dialysis Market Analysis I Confidential
Founded in: 1949
HQ: Dublin, Ireland
Type: Public
Revenue: $31.23 Bn (Global)
Website: www.medtronic.com
▪Medtronic, a global medical technology leader, has been
pioneering healthcare solutions
▪Medtronic develops and manufactures a wide range of medical
devices and therapies, impacting lives across various specialties
like cardiac rhythm management, spinal care, neurosciences,
and more
▪Currently serves over 150 countries and employs over 90,000
people
5.2.1 Medtronic
Latest News/Activity
Therapy Areas
➢General Surgery
➢Oncology
➢Gastroenterology
➢Neurology
➢Urology
➢Respiratory
Medical Specialties
➢Cardiac Surgery
➢Interventional Cardiology
➢Electrophysiology
➢Gastroenterology
➢Ear, Nose & Throat
➢Hernia
➢Spine Surgery
May,2024: Medtronic's Infuse bone graft, combined with specific devices, got FDA's
Breakthrough Device designation for a new use in spine surgery. This designation aims
to speed up approval for treating lower back problems.
April, 2024: Medtronic launches new Avalus Ultra valve, which is their most
advanced design yet for implanting and managing aortic valve replacements, building
on a decade of success with the Avalus valve
Founded in: 1949
HQ: Dublin, Ireland
Type: Public
Revenue: $31.23 Bn (Global)
Website: www.medtronic.com
▪Medtronic, a global medical technology leader, has been
pioneering healthcare solutions
▪Medtronic develops and manufactures a wide range of medical
devices and therapies, impacting lives across various specialties
like cardiac rhythm management, spinal care, neurosciences,
and more
▪Currently serves over 150 countries and employs over 90,000
people
5.2.1 Medtronic
Latest News/Activity
Therapy Areas
➢General Surgery
➢Oncology
➢Gastroenterology
➢Neurology
➢Urology
➢Respiratory
Medical Specialties
➢Cardiac Surgery
➢Interventional Cardiology
➢Electrophysiology
➢Gastroenterology
➢Ear, Nose & Throat
➢Hernia
➢Spine Surgery
May,2024: Medtronic's Infuse bone graft, combined with specific devices, got FDA's
Breakthrough Device designation for a new use in spine surgery. This designation aims
to speed up approval for treating lower back problems.
April, 2024: Medtronic launches new Avalus Ultra valve, which is their most
advanced design yet for implanting and managing aortic valve replacements, building
on a decade of success with the Avalus valve
34 A Sample Report on Austria Dialysis Market Analysis I Confidential
5.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Indications
for Telemedicine Recent Activity / Press Coverage
5.2.2 Company 2
Founded in:
HQ:
Type:
Revenue:
Website:
Solutions offered by Company
Indications
for Telemedicine Recent Activity / Press Coverage
35 A Sample Report on Austria Dialysis Market Analysis I Confidential
5.2.2 Company 2 (Continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
5.2.2 Company 2 (Continued)
Major Distribution Partners Major Vendor Partners
Partnerships Ecosystem
36 A Sample Report on Austria Dialysis Market Analysis I Confidential
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
5.2.2 Company 2 (Continued)
Company Name Type
Amount /
Duration
Year Key Pointers
Latest Deals - Mergers and Acquisitions
5.2.2 Company 2 (Continued)
37 A Sample Report on Austria Dialysis Market Analysis I Confidential
xx
xx
xx
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
5.2.2 Company 2 (Continued)
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
xx
xx
xx
2020202120222023F2024F2025F2026F2027F2028F2029F2030F
5.2.2 Company 2 (Continued)
Revenues ($Bn), 2020-2030
Breakdown of Net Revenue by Segment, 2022
1 2 3 4
▪Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
availability
▪In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
▪Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
Austria Dialysis Market Analysis
6. Reimbursement Scenario
6. Reimbursement Scenario
39 A Sample Report on Austria Dialysis Market Analysis I Confidential
6.1 Reimbursement Regulation in Austria
AGES is the primary federal department responsible for regulating in Austria for agriculture, food and feed safety control, control of infectious
diseases, veterinary medicine, radiation protection medical devices and pharmaceuticals
Austrian Medicines and Medical Devices Agency (AGES):
▪Research and Development: The agency conducts research in the fields of health and food safety to enhance scientific understanding
and develop innovative solutions to emerging challenges
▪Regulatory Support: AGES supports government authorities in developing and implementing regulations related to health and food
safety, ensuring compliance with national and European Union legislation
▪Risk Assessment and Management: The agency conducts risk assessments to identify potential hazards in medicines and other
products, and it develops strategies to manage and mitigate these risks effectively
Federal Ministry of Health (Bundesministerium für Gesundheit -BMG):
▪Develop national guidelines for healthcare policy, regulations and legislation at federal level
▪Sets standards for healthcare delivery
▪Co-ordinates with other government agencies and stakeholders
Illustrative
Regulatory Authorities Overseeing & Governing Different Aspects of Dialysis
6.1 Reimbursement Regulation in Austria
AGES is the primary federal department responsible for regulating in Austria for agriculture, food and feed safety control, control of infectious
diseases, veterinary medicine, radiation protection medical devices and pharmaceuticals
Austrian Medicines and Medical Devices Agency (AGES):
▪Research and Development: The agency conducts research in the fields of health and food safety to enhance scientific understanding
and develop innovative solutions to emerging challenges
▪Regulatory Support: AGES supports government authorities in developing and implementing regulations related to health and food
safety, ensuring compliance with national and European Union legislation
▪Risk Assessment and Management: The agency conducts risk assessments to identify potential hazards in medicines and other
products, and it develops strategies to manage and mitigate these risks effectively
Federal Ministry of Health (Bundesministerium für Gesundheit -BMG):
▪Develop national guidelines for healthcare policy, regulations and legislation at federal level
▪Sets standards for healthcare delivery
▪Co-ordinates with other government agencies and stakeholders
Illustrative
Regulatory Authorities Overseeing & Governing Different Aspects of Dialysis
40 A Sample Report on Austria Dialysis Market Analysis I Confidential
6.1 Reimbursement Regulation in Austria (Continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in Austria healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
6.1 Reimbursement Regulation in Austria (Continued)
Coverage Penetration (% Total Population) Source of Funding
Spend on Healthcare (%of Current Health Expenditure)
Reimbursement Market Trends
Public healthcare coverage is provided by the government and includes
programs like Medicare and Medicaid
Medicare is a federal program that provides healthcare coverage to individuals
who are 65 years of age or older, as well as certain younger people with
disabilities
▪Shift towards value-based care has been a significant trend in Austria healthcare system, with payers and providers increasingly focused on improving patient
outcomes and reducing costs
▪This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which
incentivize providers to deliver high-quality, cost-effective care
38.9% 37.1% 35.6% 32.5% 31.5%
44.0%
46.0% 47.7%
51.0% 51.8%
2017 2018 2019 2020 2021 2022 2023
Government Expenditure
Private Health Insurance
Out of Pocket
Other
NA NA
100% 100% 100% 100% 100%
xx
xx xx
xx xx
2019 2020 2021 2022 2023
Public Healthcare
Coverage
Private Coverage
6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy)
14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy)
Illustrative
41 A Sample Report on Austria Dialysis Market Analysis I Confidential
6.2 Reimbursement Process
The reimbursement process in Austria healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
6.2 Reimbursement Process
The reimbursement process in Austria healthcare system can be complex and can vary depending on the type of healthcare service,
the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the
service provided
▪Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for
reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential
errors or fraud
▪Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service
provided, based on the negotiated payment rates or fee schedule
▪Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost
of the service, such as deductibles, co-payments, or co-insurance
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the
topic or subject matter of interest
Illustrative
42 A Sample Report on Austria Dialysis Market Analysis I Confidential
6.3 Reimbursement Process (Continued)
The reimbursement process in Austria healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32
Illustrative
6.3 Reimbursement Process (Continued)
The reimbursement process in Austria healthcare system can be complex
and can vary depending on the type of healthcare service, the healthcare
provider, and the insurance coverage. Here are the general steps involved
in the reimbursement process:
▪Service or Treatment Provided: The healthcare provider performs a
service or treatment for the patient
▪Billing: The healthcare provider submits a claim to the insurance
company or other payer, requesting reimbursement for the service
provided
▪Adjudication: The insurance company or other payer reviews the claim
to determine whether it meets the criteria for reimbursement. This can
involve verifying the patient's eligibility, reviewing the treatment
provided, and checking for any potential errors or fraud
▪Payment: If the claim is approved, the insurance company or other
payer reimburses the healthcare provider for the service provided,
based on the negotiated payment rates or fee schedule
MoH
Private Payers Public Payers
Health Technology Assessment
PaymentCoverageCoding
Coding depends on availability code while coverage and
payment process decisions are made through an HTA.
Market Authorization
1 32
Illustrative
A division of
Life-sciences Market Research
Reports you can trust
www. insig hts10. com
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.
Reports you can trust
www. insig hts10. com
www.insights10.com
We maintain an extensive database comprising
over 30,000 syndicated market research reports
within the pharmaceuticals and healthcare sector,
offering a global, regional, and country-level
perspective. Our services also include the provision
of customized research reports, meticulously
tailored to align with your specific requirements.
At Insights10, our extensive report
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www. insig hts10. com
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& )
library spans a diverse range of
categories within the field of life
sciences.
Market Research
Reports across various
categories in healthcare
www. insig hts10. com
www.insights10.com
Digital
Health
Medical
Devices
Healthcare
Services
Rare
Diseases
Clinical
Trials
OTC &
Nutraceuticals
Pharma
(Diseases
& )
Click on the country to see the reports
available
Global Coverage
North America
•US
•Austria
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• Indonesia
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
•UAE
•Saudi Arabia
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco
available
Global Coverage
North America
•US
•Austria
Latin America
•Brazil
•Argentina
•Mexico
•Ecuador
•Venezuela
•Senegal
Europe
•UK
•Germany
•France
•Italy
•Spain
•Russia
•Netherlands
•Sweden
•Romania
•Switzerland
• Poland
• Austria
• Ireland
• Norway
• Denmark
• Belgium
• Portugal
• Ukraine
• Bulgaria
• Finland
APAC
• India
• China
• South Korea
• Japan
• Australia
• Indonesia
• Hong Kong
• New Zealand
• Philippines
• Singapore
• Malaysia
• Thailand
• Vietnam
Middle East
•UAE
•Saudi Arabia
•Turkey
•Lebanon
•Kuwait
•Qatar
Africa
•Egypt
•Kenya
•South Africa
•Algeria
•Nigeria
•Libya
•Tanzania
•Morocco
What do our reports cover?
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10
Market Overview
Growth Drivers & Growth Restraints
Epidemiology & Disease type
Market Size & Forecast
Competitive Landscape
Policy & Regulatory Landscape
Reimbursement Scenario
Recent Developments
Market Segmentation Factors Driving Future Growth
1
2
3
4
5
6
7
8
9
10
01 0302 04 05
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process
Define
precise
research
questions
Validate data
through primary
research
interviews
Gather data
through
secondary
research
Forecast
market size
and segment
analysis
Extract key
insights from
the research
findings
06
Compile &
present a
comprehensive
analytical report
Our Research Process
Bottom Up Approach
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation
Analyze product or treatment pricing
and reimbursement strategies
Evaluate consumer or patient
demographics and numbers
Predict future market
growth or decline based
on key market trends &
dynamics
Find
final
market size
Top Down Approach
Examine the total healthcare expenditure in
the targeted disease or service domain.
Assess the proportion of spending
allocated to the specific product or
treatment category.
Predict future market
growth or decline
based on key market
trends & dynamics
Find
final
market
size
Data Triangulation & Data Validation
2023
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Billion (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.
2024-
2030
Report Attribute
Quantitative Units
Pricing and Purchase
Revenue in USD Million/Billion (Mn/Bn)
Our pricing and purchase options are adaptable to
suit the specific scope of work.
Details Time Frame
Base
Year for
estimation
Forecast
Period
Report Scope
Delivery Timeline
Typically, the delivery of the final report falls within a
timeframe of 5 to 7 business days, but the exact
duration may vary depending on the project's scope.
Customization
We are pleased to offer you the option of
customizing the report to align with your specific
research requirements at no extra charge, provided
it falls within the defined scope of the project.
We have access to a multitude of highly
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www. insig hts10. com
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases
dependable data sources, supported by
years of experience that guide us in
discerning which sources are most reliable
and current for the specific information
needed.
Access to credible
data sources for
secondary research
www. insig hts10. com
www.insights10.com
Statistical
Databases
Annual
Reports
Trade
Publications
Online
Databases
Published
Research
Reports
White-
papers
Press
Releases
Reliable
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works
Expert Verified
Realistic
Comprehensive
Easy to read
Our reports present data, which is
The report is prepared using a proven methodology and insightful
research
The report is prepared by a team of highly qualified & experienced
research analysts & vetted by our local associates
The report allows you to confidently make smarter business and
strategic decisions based on realistic findings
Covers everything you would need to know about the market
including market size, competitive analysis & much more
You do not have to be a market expert to understand what really is
happening on the market and how it works
Yearly Access
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services
(Subscription)
Regulatory
Compliance
Competitive
Intelligence
Conference
Coverage
Full-Time
Engagement
Database Service
& KOL Mapping
Primary Research &
Interviews
Customized Market
Research Reports
Syndicated Market
Research Reports
Our Services
“The business decision-making process is no longer as
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks
straightforward as it used to be. It requires insights
generated at the right time, based on reliable data
interpreted in a nuanced manner for each market. We at
Insights10 are building the future of market research and
are committed to providing our clients with the right
intelligence and insights to make business decisions
quickly and efficiently.
Insights10 is a unique platform that combines deep
domain expertise, nuanced data at a country and
functional area level, and years of experience working with
some of the best organizations in the world, generating
insights that provides substantial competitive advantage.”
Dr. Purav Gandhi, Founder & CEO
Click to watch Our Introductory Video here
CEO Speaks
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, digital health,
analytics and data science. Purav
studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Anish has 15+ years of
experience in management
consulting in the Life Sciences
sector, and has worked with
diverse multinational firms in
the US, India, Middle East and
APAC regions. His primary area
of interest is Customer and
Market Strategy, Market
Access, and Digital Health with
special focus on emerging
markets like Africa, Middle East
and APAC.
Dr. Purav Gandhi
Founder & CEO
Anish Swaminathan
Director
Mukesh is an engineering graduate with
an MBA in Marketing. He is a seasoned
healthcare market research &
marketing professional with a
progressive experience of over 20
years in Life Sciences, Healthcare
services, Pharma and Medical Device
sectors. With an in-depth understanding
of primary research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare &
completed several research projects
across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Mukesh Nayak
Head – Marketing & Research
Ritu Baliya
Engagement Manager
Leadership Team
@Our Team
@Work
Beyond Work
… and many more
Pi-SM
GmbH
Our Clients
Pi-SM
GmbH
Our Clients
I've had the pleasure of availing Insights10’s services several times, and I've always
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say
been impressed by their expertise, professionalism, and dedication to providing us with
the highest quality data and insights. Whether one is looking to launch a new product,
expand into a new market, or better understand one's target customers, Insights10
insures achieving the goals.
Their team of experts has a deep understanding of the healthcare industry, and they use
their knowledge to develop customized research solutions that meet the specific needs
of each client. I highly recommend Insights10 to anyone looking for a reliable and
experienced partner in healthcare market research. They're a valuable asset to any
company that wants to succeed in this dynamic sector.
Sid Panigrahy
Founder-CEO, MediGlobo Inc.,
(Healthcare - Group Company of Omi Holdings, Inc) Tampa, Florida (USA)
What our clients say
Dear Insights10 Team, I wanted to thank you all for the great work you conducted
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say
producing the Kenya Medical and Diagnostic Laboratory Service Market Analysis. The
quality of the report was excellent, and you managed to complete it in record time. I was
also impressed by your quick turnaround on the topics discussed as a follow up after the
report's first version; you managed to gather the information required, plus a very good
analysis.
I will definitely consider working with you again if the opportunity arises, and will not
hesitate in recommending you to colleagues working in the field Thank you again for
your professionalism and team work. It was a pleasure working with you.
Lelio Marmora
CEO, The Management Lab, Geneva
Ex. Executive Director, UNITAID
What our clients say
Michael Blumberg Youssef Mallat
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Market. The insights provided by Insights10 is fantastic and
they just took less than three days to deliver the report.
What our clients say
Wissem Menad
Dr. Robert Ryan
Co Founder GFAU Pty Ltd., Australia
Co Founder – Embi, Optimum Oral care, Australia
Opusline, A part of Accenture, Paris
Senior Manager Segment Marketing
Performance Health,London, UK
Chief Executive Officer, Innova Therapeutics, Inc., USA
We engaged INSIGHTS10 to assist us with our research requirements
for the Oral Care Market sector in Australia. We been very impressed
with the depth and quality of data and equally with the personal
service we experience from the management team on our account.
They understand our business, our challenges and our goals. There is
a real sense of partnership as we continue to work together.
The info you delivered on the European Patient
Support Market with a deep dive into countries
like Spain, Germany, Italy, France, UK and
Belgium, was very useful.
Insights10 has been a great resource for
getting a detailed report on the UK
Physiotherapy Market. Usually I had multiple
sources for getting global reports, but now I
can get in-depth country reports from
Insights10 which has been a game changer.
We were looking for very specific information regarding Abu Dhabi
Oncology Market. The insights provided by Insights10 is fantastic and
they just took less than three days to deliver the report.
What our clients say
Thank You
www. insig hts10. com
www.insights10.com
Email: [email protected]
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?
www. insig hts10. com
www.insights10.com
Email: [email protected]
India: (+91) 931 639 7935
We would be happy to help.
Do you have
any questions?
Categories
ScienceDownload
Download Slideshow Get the original presentation fileQuick Actions
Statistics
- Views 42
- Slides 63
- Age 493 days
Related Slideshows
23
Earthquakes_Type of Faults_Science G8.pptx
OctabellFabila1
32 views
15
Quiz #1 Science 10 in the first quarter for jhs
HendrixAntonniAmante
32 views
9
Astronomy history from long ago till doday
ssuserbd9abe
31 views
9
Great history of astronomy from long ago till today
ssuserbd9abe
29 views
20
EARTHQUAKE-DRILL.powerpoint.............
chalobrido8
32 views
9
History of astronomy from old times to the present times
ssuserbd9abe
31 views